Metformin hydrochloride improves hepatic glucolipid metabolism in diabetes progression through SIRT5-mediated ECHA desuccinylation

Metformin hydrochloride improves hepatic glucolipid metabolism in diabetes progression through SIRT5-mediated ECHA desuccinylation

Abstract The management of hyperglycemia and lipid metabolism is pivotal for the treatment of type 2 diabetes mellitus (T2DM). Metformin hydrochloride (DMBG) remains the most widely prescribed medication for this condition. This study aimed to elucidate the effects and underlying mechanisms by which...

Cijeli opis

Bibliografski detalji
Glavni autori: Liang Tang, Qing Sun, Jinling Luo, Suying Peng
Format: Članak
Jezik:English
Izdano: Nature Portfolio 2025-03-01
Serija:Scientific Reports
Teme:
Metformin hydrochloride
Hyperglycemia
Lipid metabolism
Desuccinylation
ECHA
Online pristup:https://doi.org/10.1038/s41598-025-92716-z

Internet

https://doi.org/10.1038/s41598-025-92716-z

Slični predmeti